Cell Cryopreservation Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End-use Channel), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cell Cryopreservation Market size was more than USD 4.1 billion in 2026 and is set to grow at a 10.83% CAGR between 2027 and 2036, attaining USD 11.46 billion by 2036. The industry revenue for 2027 is assessed at USD 4.47 billion.
Get more details on this report
Request Free Sample ReportCell Cryopreservation Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 42.89% share due to advanced biobanking infrastructure, strong research institutions, and widespread use of controlled freezing systems across cell therapy and regenerative medicine workflows.
- Asia Pacific grows at 22.66% CAGR driven by expanding biomedical research capacity, rising biorepository development, and increasing adoption of standardized cryostorage in clinical and manufacturing settings.
Segment Momentum
- Consumables held a 44.38% share in 2026 because cryovials, media, reagents, and related materials are required for every preservation cycle, creating recurring demand across laboratories, biobanks, and clinical facilities.
- Oocytes and embryotic cells are the fastest-growing application segment as preservation becomes increasingly important for managing reproductive material between collection, treatment planning, and future use.
Market Expansion Drivers
- Rapid expansion of biopharmaceutical pipelines increasing demand for advanced cell preservation systems.
- Growth in stem cell and regenerative medicine research driving cryogenic storage demand.
- Rising adoption of global biobanking and personalized medicine accelerating long-term cell storage.
Leading Market Participants
- Prominent companies in the cell cryopreservation market include Thermo Fisher Scientific Inc. (USA), Merck KGaA (Germany), Sartorius AG (Germany), BioLife Solutions Inc. (USA), PromoCell GmbH (Germany), Lonza Group AG (Switzerland), HiMedia Laboratories Pvt. Ltd. (India), Creative Biolabs Inc. (USA), Corning Incorporated (USA), Cytiva (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 4.1 billion
- 2027 Estimated Market Size: USD 4.47 billion.
- Projected Market Size: USD 11.46 billion by 2036
- Growth Forecast: 10.83% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Consumables (Product) | Stem Cells (Application) | Biopharmaceutical & Pharmaceutical Companies (End-use Channel)
- Emerging Opportunity Segment: Consumables (Product) | Oocytes and Embryotic Cells (Application) | Biobanks (End-use Channel)
Market Growth Drivers and Industry Trends
Rapid expansion of biopharmaceutical pipelines increasing demand for advanced cell preservation systems
Rapid growth in biopharmaceutical development is driving the cell cryopreservation market as research and manufacturing pipelines increasingly depend on maintaining viable cells throughout development, testing, and production processes. Advanced preservation systems help protect cellular integrity during storage and transportation, supporting reproducibility across different stages of therapeutic development. As developers work with increasingly diverse cell-based materials, demand is rising for controlled cryogenic environments, specialized storage equipment, and preservation protocols capable of maintaining cell quality over extended periods.
Growth in stem cell and regenerative medicine research driving cryogenic storage demand
The cell cryopreservation market is gaining traction from expanding research into stem cells and regenerative medicine, where preserving viable biological material is essential for laboratory studies and future therapeutic applications. Stem cell samples often require carefully controlled freezing and storage conditions to maintain their functional characteristics before subsequent research or clinical use. Increasing activity across cell-based research programs is therefore encouraging laboratories, research institutions, and specialized facilities to invest in reliable cryogenic storage infrastructure and preservation solutions suited to sensitive cellular materials.
Rising adoption of global biobanking and personalized medicine accelerating long-term cell storage
Growing investment in biobanking and personalized healthcare is creating sustained demand within the cell cryopreservation market as biological samples increasingly need to remain viable and accessible over long storage periods. Biobanks collect and preserve cellular materials for research, disease investigation, biomarker analysis, and potential future therapeutic applications, requiring dependable temperature control and storage management. Personalized medicine further increases the importance of maintaining patient-specific biological materials with traceability and sample integrity, encouraging adoption of cryogenic systems designed for secure long-term preservation.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rapid expansion of biopharmaceutical pipelines increasing demand for advanced cell preservation systems | 2.50% | Moderate | North America, Europe | High | Near Term |
| Growth in stem cell and regenerative medicine research driving cryogenic storage demand | 2.30% | High | North America, Asia Pacific | High | Mid Term |
| Rising adoption of global biobanking and personalized medicine accelerating long-term cell storage | 1.80% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the cell cryopreservation market, North America held the largest share in 2026 at 42.89%, supported by its advanced biotechnology and healthcare ecosystem and strong demand for the long-term preservation of cells used in research and therapeutic applications. The region benefits from substantial activity in cell-based research, regenerative medicine, biobanking, and advanced therapeutic development, while established laboratory infrastructure and technological capabilities continue to reinforce the adoption of cryopreservation solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is positioned as the fastest-growing region, supported by expanding biotechnology research, increasing investment in life sciences infrastructure, and the growing development of cell-based therapies. Rising interest in regenerative medicine, biobanking, and personalized healthcare is increasing the need for reliable cell storage and preservation capabilities. Improving research capacity and the continued expansion of healthcare and biotechnology sectors are expected to further accelerate market growth across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Research Quality PreservationGermany prioritizes high-quality cell cryopreservation systems that support biomedical research, clinical laboratories, and advanced therapeutic development. German institutions emphasize standardized preservation protocols to ensure consistent sample integrity across research and healthcare applications.
France 🇫🇷
Clinical Sample ManagementFrance is enhancing cell cryopreservation capabilities to strengthen clinical research, biobanking, and personalized medicine initiatives. French healthcare and research institutions prioritize dependable storage technologies that preserve sample quality while meeting rigorous laboratory standards.
Italy 🇮🇹
Translational Research SupportItaly continues to develop its cell cryopreservation market through expanding biomedical research and academic collaboration. Italian laboratories increasingly adopt advanced cryopreservation solutions that support long-term sample preservation and improve research continuity across life science applications.
Japan 🇯🇵
Regenerative Medicine ReadinessJapan continues to strengthen its cell cryopreservation market through sustained activity in regenerative medicine and stem cell research. Japanese laboratories focus on reliable preservation technologies that maintain long-term cell quality while supporting translational and clinical research programs.
South Korea 🇰🇷
Cell Therapy ManufacturingSouth Korea is expanding investment in cell cryopreservation to support biopharmaceutical production and cell therapy commercialization. Companies increasingly adopt automated preservation systems that improve operational consistency, sample traceability, and manufacturing efficiency across advanced therapeutic applications.
United States 🇺🇸
Biobanking Infrastructure FocusThe U.S. cell cryopreservation market is supported by expanding biobanking activities, regenerative medicine research, and cell therapy development. Organizations increasingly invest in advanced preservation technologies that maintain cell viability while supporting clinical research and commercial manufacturing requirements.
Segment Leadership and Growth Trends
Cell Cryopreservation Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Consumables (Largest & Fastest-Growing Segment)
The consumables segment dominated the cell cryopreservation market with a 44.38% share in 2026 and is also expected to be the fastest-growing segment, supported by the recurring need for cryoprotective agents, vials, bags, media, and other materials used throughout cell preservation workflows. The expansion of cell-based research, regenerative medicine, biobanking, and advanced therapeutic development is increasing the volume of cells requiring long-term storage, thereby strengthening demand for consumable products. In addition, the repeated use and regular replacement of these materials create sustained purchasing requirements across research institutions, laboratories, and clinical facilities. Growing emphasis on maintaining cell viability, sample integrity, and standardized preservation procedures is further supporting the segment's leading position.
Application Segment Analysis: Stem Cells (Largest Segment) vs Oocytes and Embryotic Cells (Fastest-Growing Segment)
The stem cells segment held the largest share of the cell cryopreservation market at 32.83% in 2026, driven by the expanding role of stem cells in regenerative medicine, disease research, drug development, and therapeutic applications. Cryopreservation enables the long-term storage of valuable stem cell samples while helping preserve their biological characteristics for future use. Increasing investment in cell-based research and the growing need to establish reliable cell inventories are supporting demand for advanced preservation solutions. The broader development of personalized and regenerative therapies is also reinforcing the importance of effective stem cell storage.
The oocytes and embryotic cells segment is expected to be the fastest-growing segment, supported by rising demand for fertility preservation and assisted reproductive procedures. Cryopreservation provides greater flexibility in reproductive treatment by enabling oocytes and embryotic cells to be stored for use at a later stage. Advances in preservation techniques are improving the reliability of storage processes and supporting wider adoption across fertility clinics and reproductive medicine settings. Growing awareness of reproductive planning and the increasing availability of fertility preservation services are expected to contribute to continued segment expansion.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Cell Freezing Media, Equipment, Consumables | Consumables | Consumables |
| Application | Stem Cells, Oocytes and Embryotic Cells, Sperm Cells, Hepatocytes, Others | Stem Cells | Oocytes and Embryotic Cells |
| End-use Channel | Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF Clinics, Others | Biopharmaceutical & Pharmaceutical Companies | Biobanks |
Competitive Landscape and Market Positioning
Prominent players in the cell cryopreservation market:
1. Thermo Fisher Scientific Inc. (USA)
2. Merck KGaA (Germany)
3. Sartorius AG (Germany)
4. BioLife Solutions Inc. (USA)
5. PromoCell GmbH (Germany)
6. Lonza Group AG (Switzerland)
7. HiMedia Laboratories Pvt. Ltd. (India)
8. Creative Biolabs Inc. (USA)
9. Corning Incorporated (USA)
10. Cytiva (USA)
The cell cryopreservation market is witnessing increasing emphasis on advanced preservation technologies and process optimization to improve long-term cell viability and storage efficiency. Market participants are strengthening research capabilities to develop next-generation cryogenic solutions that support growing demand from regenerative medicine and biobanking applications. The industry is also seeing wider adoption of automated storage systems and monitoring technologies aimed at enhancing consistency, scalability, and sample integrity across preservation workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (USA) | |||||||
| Merck KGaA (Germany) | |||||||
| Sartorius AG (Germany) | |||||||
| BioLife Solutions Inc. (USA) | |||||||
| PromoCell GmbH (Germany) | |||||||
| Lonza Group AG (Switzerland) | |||||||
| HiMedia Laboratories Pvt. Ltd. (India) | |||||||
| Creative Biolabs Inc. (USA) | |||||||
| Corning Incorporated (USA) | |||||||
| Cytiva (USA). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Bioserve India | Jul-24 | Bioserve India introduced a comprehensive suite of life science products, including specialized stem cell media for cryopreservation, cellular assays, and stem cell reprogramming kits. The portfolio expansion scales localized clinical infrastructure and reinforces biological research and therapeutic discovery within India's regenerative medicine sector. |
| Acorn Biolabs | Jun-24 | Acorn Biolabs raised USD 11 million in a Series A funding round to scale commercial access to regenerative medicine via its specialized cell preservation platform. The investment accelerates operational growth initiatives and advances the firm’s capabilities in long-term cell storage for future therapeutic and personalized medicine applications. |
| Pluristyx | Apr-24 | Pluristyx launched its proprietary PluriFreeze cryopreservation media, an animal-origin-free, synthetic stem cell storage solution offered initially in a Research Use Only formulation. The media expands the firm's panCELLa platform, enhancing post-thaw cell viability and accelerating automated induced pluripotent stem cell therapeutic workflows. |
| Thermo Fisher Scientific | Apr-24 | Thermo Fisher Scientific introduced its TSX Universal Series ultra-low temperature freezers, achieving official ENERGY STAR certification alongside improved thermal recovery times. The laboratory equipment engineering update delivers up to 33% energy savings to optimize sustainability and infrastructure capacity across clinical biobanking facilities. |
| SCTbio | Jun-23 | Contract development and manufacturing organization SCTbio entered a strategic collaboration with Cyto-care.eu GmbH, a specialist in cell therapy solutions. The logistical and technical partnership aims to improve cryopreservation protocols and standardize raw-material freezing workflows for advanced cell therapy development throughout Europe. |
| BioLife Solutions, Inc. | Jun-23 | BioLife Solutions, Inc. commercialized its high-capacity IntelliRate i67C tabletop controlled-rate freezer, expanding its specialized line of biological freezing systems to three distinct configurations. The device launch addresses direct customer requirements for high-volume, automated production and cryopreservation of delicate cell treatments. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cell Cryopreservation Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Preservation Method | Controlled-Rate Freezing, Vitrification, Slow Freezing |
| Workflow Stage | Cell Collection, Cryopreservation, Thawing and Recovery, Long-Term Storage |
| Ownership Model | In-House Storage, Contract Storage, Hybrid Storage |
Cell Cryopreservation Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Cell Therapy Manufacturing Ecosystem Assessment |
|
| Biobanking Infrastructure & Capacity Outlook |
|
| Cold Chain Logistics & Cryostorage Network Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of cell cryopreservation?
What is the anticipated CAGR of the cell cryopreservation industry?
How are expanding biopharmaceutical pipelines influencing procurement in the cell cryopreservation market?
Why are biobanking and regenerative medicine strengthening demand for advanced cell cryopreservation solutions?
What drives the leadership of Consumables in the cell cryopreservation market?
Which application segment is expanding fastest in the cell cryopreservation market?
Why does North America dominate the cell cryopreservation market?
What is driving Asia Pacific growth in cell cryopreservation market?
Which organizations are considered leaders in the cell cryopreservation landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization